Autori: Gershlick Anthony H
| Naslov | Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction (Article) |
| Autori | Bainey Kevin R Fresco Claudio Zheng Yinggan Halvorsen Sigrun Carvalho Antonio C Ostojic Miodrag C  Goldstein Patrick Gershlick Anthony H Westerhout Cynthia M Van de Werf Frans Armstrong Paul W
|
| Info | HEART, (2016), vol. 102 br. 7, str. 527-533 |
| Projekat | Boehringer Ingelheim |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged (Article) |
| Autori | Gershlick Anthony H Westerhout Cynthia M Armstrong Paul W Huber Kurt Halvorsen Sigrun Steg Philippe Gabriel Ostojic Miodrag C Goldstein Patrick Carvalho Antonio C Van de Werf Frans Wilcox Robert G
|
| Info | HEART, (2015), vol. 101 br. 9, str. 692-698 |
| Projekat | Boehringer Ingelheim |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction (Article) |
| Autori | Armstrong Paul W Gershlick Anthony H Goldstein Patrick Wilcox Robert G Danays Thierry Sr Lambert Yves Sulimov Vitaly Rosell Ortiz Fernando Ostojic Miodrag C Welsh Robert C Carvalho Antonio C Nanas John Arntz Hans-Richard Halvorsen Sigrun Huber Kurt Grajek Stefan Fresco Claudio Bluhmki Erich Regelin Anne Vandenberghe Katleen Bogaerts Kris Van de Werf Frans
|
| Info | NEW ENGLAND JOURNAL OF MEDICINE, (2013), vol. 368 br. 15, str. 1379-1387 |
| Projekat | Boehringer Ingelheim; Eli Lilly; Merck; Roche; Daiichi Sankyo; Medicines Company; AstraZeneca; Sanofi; Bayer; Schering-Plough; Sanofi-Aventis; Bristol-Myers Squibb; Abbott; Medtronic; Edwards Lifesciences; Servier; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
